California State Teachers Retirement System Adverum Biotechnologies, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $30,310 - $50,142	-37,420 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $11,833 - $18,760	-9,621 Reduced 20.45%	37,420 $49,000
Q4 2021 Feb 15, 2022	SELL	$1.74 - $2.4 $83,471 - $115,132	-47,972 Reduced 50.49%	47,041 $83,000
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $51,588 - $89,287	-24,802 Reduced 20.7%	95,013 $206,000
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $48,414 - $152,159	-14,409 Reduced 10.74%	119,815 $419,000
Q1 2021 May 18, 2021	SELL	$9.26 - $14.36 $3,750 - $5,815	-405 Reduced 0.3%	134,224 $1.32 Million
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $30,533 - $44,248	3,103 Added 2.36%	134,629 $1.46 Million
Q3 2020 Nov 17, 2020	BUY	$10.3 - $21.64 $220,605 - $463,485	21,418 Added 19.45%	131,526 $1.36 Million
Q2 2020 Aug 17, 2020	BUY	$8.53 - $25.64 $119,479 - $359,139	14,007 Added 14.58%	110,108 $2.3 Million
Q1 2020 May 13, 2020	BUY	$7.98 - $16.32 $108,966 - $222,849	13,655 Added 16.56%	96,101 $939,000
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $16,926 - $40,399	-3,306 Reduced 3.86%	82,446 $950,000
Q3 2019 Nov 15, 2019	BUY	$5.24 - $15.89 $20,776 - $63,003	3,965 Added 4.85%	85,752 $467,000
Q2 2019 Aug 14, 2019	SELL	$5.1 - $11.89 $10,623 - $24,766	-2,083 Reduced 2.48%	81,787 $972,000
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $2,479 - $4,187	551 Added 0.66%	83,870 $507,000
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $441,590 - $574,901	83,319 New	83,319 $442,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account